CTS Corporation Announces Completion of the Acquisition of Millar Holdings

By GlobeNewswire

LISLE, Ill., Oct. 23, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) today announced that it has completed the acquisition of Millar Holdings, Inc. (“Millar”) for $50 million, net of cash acquired and debt assumed, with additional contingent consideration payable subject to the achievement of specified financial performance targets. Millar specializes in the design, development, and manufacturing of advanced pressure sensing technologies for medical devices, life sciences, and industrial applications. The acquisition strengthens CTS’s position in advanced sensing technologies and expands its presence in diversified end markets.

“We are excited to welcome the Millar team to CTS,” said Pratik Trivedi, President and Chief Executive Officer of CTS Corporation. “Millar represents a highly strategic addition to our portfolio, expanding our presence in medical sensing while adding differentiated technology, talented employees, and strong customer relationships. We believe the combination will enhance our ability to deliver innovative sensing solutions to customers worldwide and create long-term value for our shareholders.”

Tim Daugherty, Chief Executive Officer of Millar, added, “Joining CTS marks an exciting new chapter for Millar and an incredible opportunity to build on everything our team has accomplished over the past 55-plus years. We've always been passionate about pushing the boundaries of sensor technology and helping our customers bring innovative solutions to life. With CTS's global reach, complementary technologies, and engineering expertise, we're positioned to accelerate innovation, expand our capabilities, and create even greater value for the customers and markets we serve.”

About CTS Corporation

CTS is a leading designer and manufacturer of products that Sense, Connect, and Move. The Company manufactures sensors, connectivity components, and actuators for applications in the aerospace and defense, industrial, medical, and transportation markets. CTS reported sales of approximately $564 million for the twelve months ended June 30, 2026. More information is available at www.ctscorp.com.

Investor Contact:
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue

Lisle, IL 60532 USA
+1 (630) 577-8800
ashish.agrawal@ctscorp.com

Forward-Looking Statements

This press release contains forward-looking statements regarding anticipated benefits of the acquisition, future growth opportunities, and expected business performance. Actual results may differ materially from those expressed or implied by such statements due to various risks and uncertainties. CTS undertakes no obligation to update any forward-looking statements except as required by law.


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.